...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: What's the deal with Zenith?
3
Jun 21, 2023 04:54PM
3
Jun 22, 2023 07:41AM
6
Jun 22, 2023 02:26PM
3
Jun 23, 2023 01:54AM

Oh how could I forget. For the costs, in addition to the ones I've pointed in the previous post you would also have to add in the $6 million loan to Hepalink plus 2 years of unpaid interest which I think is in US$ and whatever we owe Eversana. 

That $40 million KK2 is taliking about may be in the distant rear view mirror.

tada 

3
Jun 23, 2023 10:24AM
5
Jun 24, 2023 08:49AM
Share
New Message
Please login to post a reply